Related Experiment Video
Updated: Feb 19, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis
1Department of Laboratory Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA.
Insights
Flow cytometry is crucial for diagnosing acute myeloid leukemia (AML). This review covers immunophenotyping strategies, antibody panels, and markers for AML subclassification and minimal residual disease detection.
Area of Science:
- Hematology
- Immunology
- Clinical Pathology
Background:
- Flow cytometry is essential for acute myeloid leukemia (AML) diagnosis and subclassification.
- Multiparametric flow cytometry offers efficient and highly sensitive immunophenotyping.
- Accurate subclassification aids in treatment selection and prognosis.
Purpose of the Study:
- To review the utility of flow cytometry in acute myeloid leukemia (AML).
- To outline general gating strategies and antibody panels for routine AML analysis.
- To discuss markers for lineage assignment and differential diagnosis of challenging AML entities.
Main Methods:
- Review of established flow cytometry protocols and literature.
- Description of multiparametric immunophenotyping approaches.
- Analysis of diagnostic immunophenotypic features for AML subclassification.
Main Results:
- Standardized gating strategies and antibody panels facilitate efficient AML diagnosis.
- Specific markers aid in lineage assignment and identification of difficult-to-classify AML cases.
- Flow cytometry principles for minimal residual disease detection are presented.
Conclusions:
- Flow cytometry immunophenotyping is a cornerstone in AML diagnosis and subclassification.
- Comprehensive antibody panels and strategic gating improve diagnostic accuracy.
- The technique is valuable for monitoring treatment response through minimal residual disease detection.
Abstract:
Flow cytometry plays an indispensible role in the diagnosis and subclassification of acute myeloid leukemia (AML). Using a multiparametric approach, flow cytometry immunophenotyping has the advantage of efficiency with high sensitivity. This article reviews the general gating strategy, antibody panels for routine analysis, and additional markers for lineage assignment in the subclassification of AML. Also discussed are diagnostic immunophenotypic features of hard-to-classify entities considered within the differential diagnosis of AML. Finally, briefly presented are the principles underlying the use of flow cytometry for minimal residual disease detection.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025